ACCESS TO BIOLOGIC TREATMENT IN RHEUMATOID ARTHRITIS IN CENTRAL AND EASTERN EUROPEAN (CEE) COUNTRIES

被引：0

作者：

Orlewska, E. ^{[1
]}

Ancuta, I ^{[2
]}

Anic, B. ^{[3
]}

Codreanu, C. ^{[4
]}

Damjanov, N. ^{[5
]}

Djukic, P. ^{[6
]}

Gulacsi, L. ^{[7
]}

Ionescu, R. ^{[8
]}

Marinchev, L. ^{[9
]}

Nasonov, E. L. ^{[10
]}

Pentek, M. ^{[11
]}

Praprotnik, S. ^{[12
]}

Rashkov, R. ^{[9
]}

Skoupa, J. ^{[13
]}

Tlustochowicz, W. ^{[14
]}

Tlustochowicz, M. ^{[14
]}

Tomsic, M. ^{[15
]}

Veldi, T. ^{[16
]}

Vojinovic, J. ^{[17
]}

Wiland, P. ^{[18
]}

机构：

[1] Ctr Pharmacoecon, Warsaw, Poland

[2] Clin Inst Ion Cantacuzino, Bucharest, Romania

[3] Clin Hosp Zagreb, Zagreb, Croatia

[4] Method Rheumatol Ctr Prof Dr Ion Stoia, Bucharest, Romania

[5] Inst reumatologiju, Belgrade, Serbia

[6] Consultant Hlth Econ & Management, Belgrade, Serbia

[7] Corvinus Univ Budapest, Budapest, Hungary

[8] Univ Med, St Maria UMF Carol Davila Hosp, Bucharest, Romania

[9] Univ Hosp St Ivan, Sofia, Bulgaria

[10] Inst RAMS, Moscow, Russia

[11] Corvinus Univ, Budapest, Hungary

[12] Univ Med Ctr, Ljubljana, Slovenia

[13] Pharma projects SRO, Prague, Czech Republic

[14] Military Med Inst, Warsaw, Poland

[15] Univ Med Ctr, Ljubljana, Slovenia

[16] East Tallinn Cent Hosp, Tallinn, Estonia

[17] Klinicki centar Nis, Nish, Serbia

[18] Med Univ, Wroclaw, Poland

来源：

VALUE IN HEALTH | 2010年 / 13卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)72642-5

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A133 / A133

页数：1

共 50 条

[21] Leveling the field in the treatment of rheumatoid arthritis with biologic therapies: equal access for equal efficacy
Anthony S. Russell
Wojtek P. Olszynski
K. S. Davison
Cheryl Koehn
Boulos Haraoui
Clinical Rheumatology, 2010, 29 : 233 - 239
[22] Leveling the field in the treatment of rheumatoid arthritis with biologic therapies: equal access for equal efficacy
Russell, Anthony S.
Olszynski, Wojtek P.
Davison, K. S.
Koehn, Cheryl
Haraoui, Boulos
CLINICAL RHEUMATOLOGY, 2010, 29 (03) : 233 - 239
[23] Inequities in Access to Biologic Disease-Modifying Anti-Rheumatic Drugs for Patients with Rheumatoid Arthritis Across 46 European Countries.
Putrik, Polina
Ramiro, Sofia
Pavlova, Milena
Kvien, Tore K.
Sokka, Tuulikki
Uhlig, Till
Boonen, Annelies
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S784 - S784
[24] Patients’ access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries
P. A. Laires
F. Exposto
R. Mesquita
A. P. Martins
L. Cunha-Miranda
J. E. Fonseca
The European Journal of Health Economics, 2013, 14 : 875 - 885
[25] EXPLANATORY FACTORS FOR THE RHEUMATOID ARTHRITIS PATIENTS' ACCESS TO BIOLOGICAL AGENTS IN 15 EUROPEAN COUNTRIES
Laires, P. A.
Exposto, F.
Barosa, P.
Hormigos, B.
Martins, A. P.
VALUE IN HEALTH, 2011, 14 (07) : A316 - A316
[26] Patients' access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries
Laires, P. A.
Exposto, F.
Mesquita, R.
Martins, A. P.
Cunha-Miranda, L.
Fonseca, J. E.
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2013, 14 (06): : 875 - 885
[27] An overview of central and eastern European countries
Chang, N
Gale, A
Whyte, I
Thomas, A
PROCEEDINGS OF THE INSTITUTION OF CIVIL ENGINEERS-CIVIL ENGINEERING, 2001, 144 : 46 - 62
[28] Emerging biologic drugs for the treatment of rheumatoid arthritis
Puppo, F
Murdaca, G
Ghio, M
Indiveri, F
AUTOIMMUNITY REVIEWS, 2005, 4 (08) : 537 - 541
[29] The Use of Biologic Therapies in the Treatment of Rheumatoid Arthritis
Wang, Dashan
Li, Yan
Liu, Yuan
Shi, Guixiu
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2014, 15 (06) : 542 - 548
[30] Novel biologic approaches to the treatment of rheumatoid arthritis
Sany, J
REVUE DU RHUMATISME, 1999, 66 (11): : 548 - 559

← 1 2 3 4 5 →